Dec 10, 2025
Advancement in ocular science with Akriti ophthalmic
seen from China
seen from United States
seen from United Kingdom
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from United States
seen from China
seen from T1
seen from United States
seen from United States
seen from United States
seen from United States
seen from China
seen from Netherlands
seen from Yemen
seen from United States
Advancement in ocular science with Akriti ophthalmic
Top Players & Trends in the Amniotic Membrane Market 2024-2032
The Amniotic Membrane Market was valued at USD 3.65 billion in 2023 and is projected to reach USD 10.18 billion by 2032, growing at a robust CAGR of 12.10% during the forecast period of 2024 to 2032. The increasing demand for advanced wound care products, coupled with the expanding application of amniotic membranes in regenerative medicine and surgical procedures, is propelling the market's growth globally.
Key Market Drivers
The growing prevalence of chronic wounds, such as diabetic foot ulcers and venous leg ulcers, is significantly boosting the demand for amniotic membrane-based products. Known for their anti-inflammatory, antimicrobial, and pain-reducing properties, amniotic membranes have become a vital component in wound management and healing.
Additionally, the adoption of regenerative medicine is on the rise, with amniotic membranes playing a crucial role in tissue engineering and stem cell therapy. These membranes are also widely used in ophthalmology, orthopedics, and dermatology due to their ability to accelerate tissue repair and reduce scarring.
Innovations in cryopreservation and tissue processing technologies have further enhanced the efficacy and availability of amniotic membrane products. With increasing investments in healthcare infrastructure and the growing awareness of the benefits of advanced wound care, the market is poised for substantial growth.
Regional Insights
North America leads the global amniotic membrane market, driven by advanced healthcare systems, a strong focus on research and development, and high adoption of regenerative therapies. Meanwhile, the Asia-Pacific region is expected to witness significant growth due to increasing healthcare expenditure, the rising prevalence of chronic diseases, and growing awareness about advanced treatment options.
Get Free Sample Report@ https://www.snsinsider.com/sample-request/4647
Market Outlook
The amniotic membrane market is set to experience unprecedented growth, fueled by continuous advancements in biotechnology and tissue engineering. Key players are focusing on strategic collaborations, product launches, and expanding their geographic reach to capitalize on the growing demand for amniotic membrane-based products. The market's promising trajectory is also supported by favorable reimbursement policies and increased funding for regenerative medicine research.
About Us
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us
Akash Anand – Head of Business Development & Strategy Email: [email protected] Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
AM Potential in Tissue Engineering to Drive Amniotic Membrane Market’s Growth
Triton Market Research presents the Global Amniotic Membrane Market report sectioned by End-users (Specialized Clinics, Hospitals, Ambulatory Surgical Wounds, Research Centers & Laboratories), Application (Ophthalmology, Surgical Wounds, Other Applications), Type (Lyophilization Amniotic Membrane, Cryopreserved Amniotic Membrane), and by Geography (Latin America, Asia-Pacific, Europe, North America, Middle East and Africa). The report also discusses the Market Summary, Industry Outlook, Impact of COVID-19, Key Insights, Porter’s Five Forces Analysis, Market Attractiveness Index, Vendor Scorecard, Key Market Strategies, Drivers, Challenges, Opportunities, Competitive Landscape, Research Methodology & Scope, Global Market Size, Forecasts & Analysis (2022-2028).
Based on Triton’s research report, the global amniotic membrane market is expected to grow at a CAGR of 7.01% during the forecast period 2022-2028.
Request Free Sample Report:
https://www.tritonmarketresearch.com/reports/amniotic-membrane-market#request-free-sample
The amniotic membrane refers to the innermost layer of the fetal placenta. It is used for various treatments, including ocular surface repair and tissue transplantation.
Amniotic membrane or amnion has shown potential to be used as a scaffold in numerous tissue engineering applications. In this regard, the genipin-crosslinked group (clAM) of human amniotic membranes has better biostability and biocompatibility. Therefore, the application of amnion in tissue engineering creates novel growth opportunities for the amniotic membrane market globally.
On the contrary, the use of an amniotic membrane is limited as its use in treating lung and other organ damages is still under research. Hence, the limited use of amnion restricts the amniotic membrane market’s global growth.
The Asia-Pacific region is anticipated to witness the fastest growth over the forecast period. The region’s robust growth is mainly owing to the growing applications of amnion across China, India, and South Korea. In China, the rising number of accidents and cosmetic surgery trends have increased the application of AM for various treatments. The demand for eye surgeries to prevent glasses is another reason supporting amniotic membrane use in eye treatments. Therefore, as stated above, all these factors drive the amniotic membrane market on a progressive path across the region.
The notable companies in the amniotic membrane market include Sky Biologics LLC, Human Regenerative Technologies, Labtician Ophthalmics Inc, Amino Technology LLC, Surgenix LLC, Organogenesis, MiMedx, Amniox Medical Inc, Celularity Inc, Integra Lifescience Corp, Bio Tissue Inc, Smith and Nephew Plc, Surgilogix LLC, and Katena Products Inc.
The market is heavily fragmented; however, it is expected to witness significant development over the forecast period. The barrier of entry is high as players require high capital investment in research, clinical trials, and more. Hence, the threat of new players is low. Further, since the market is emerging with no product differentiation, innovation and research are expected to drive the competition among existing players. This indicates the competition levels to be moderate over the forecast period.
Contact Us:
Phone: +44 7441 911839
Amniotic Membrane Market: Significance & Global Performance
Amniotic membrane or amnion, a thin membrane on the inner side of the fetal placenta and composed of the epithelium, has emerged as an ideal source for tissue transplantation. Moreover, amnion has an array of biological properties, making it attractive for use in various surgical procedures, including ocular surface reconstruction and tissue engineering.
The advancements in anatomy have triggered significant investments in research and development of amniotic membrane applications. While AM has shown beneficial results in burn injuries, the upsurge in R&D investments has increased its use in eye surgery, cell therapy, stem cell research, and more, boosting the amniotic membrane market growth prospects.
In fact, the identification of new stem cells has increased the membrane’s potential, making it ideal for developing regenerative medicines. For instance, Organogenesis Holdings Inc, a leading regenerative medicine company, gained approval from the US FDA for ReNu, a cryopreserved amniotic suspension allograft, to manage symptoms related to knee osteoarthritis.
Amniotic Membrane Market - Global & Regional Trends
As per estimates, the global amniotic membrane market will display revenue growth at a CAGR of 7.01% during the forecast period 2022-2028.
Considering the evolving healthcare sector, the amniotic membrane market is expected to witness tremendous growth in the Asia-Pacific nations. Estimates suggest that approximately half a billion people in the region will be 65 or older by 2025. This change in demographics, in addition to a shift in consumer expectations, will widen the market’s scope. In this regard, the growing demand for chronic care management will expand amnion application in ophthalmology, burn injuries, and cosmetic surgeries, among others.
Additionally, amniotic membrane transplantation has gained momentum in various conjunctival and corneal diseases, signaling opportunistic growth for players in the APAC region. Considering its growth in North America, amnions have proven advantageous in treating limbal stem cell deficiency, providing support and protection to transplanted limbal tissues and stem cells. Recently, in Canada, numerous techniques have been developed to dehydrate amnion while preserving the wound-healing properties to formulate a temperature-stable allograft.
Furthermore, the United Kingdom is the center of research and development of amniotic membrane applications in Europe. Several hospitals, such as NuVision, have gained expertise in providing AM treatments. Amniotic membrane treatments are gaining center stage across the nation, given the technological advancements. For instance, in November 2021, several ophthalmologists shared their innovations of AM application in treating ocular surface conditions through a webinar sponsored by NuVision Biotherapies Ltd.
Market by Application – Expert Outlook
Surgical Wounds: Human amniotic membrane has been used for treating acute and chronic wounds, decreasing infection and pain while accelerating the healing time. The surgical wound segment dominates the overall market and is expected to maintain its stronghold till 2028. Although a plethora of wound dressings are available, chronic wounds remain a major medical concern. As a result, chronic wounds awareness programs largely support amnion application. For instance, the Wound Healing and Hyperbaric Center at Carteret Health Care, a Healogic Network member, is engaged in raising awareness of chronic wounds, providing advanced therapies.
Ophthalmology: The rise in chronic and infectious diseases has resulted in a global rise in surgeries, boosting the market’s potential. Amniotic membrane is rapidly used in ophthalmic surgeries to initiate faster recovery and decrease inflammation. Amnion has become crucial in eye treatments, given its anti-scarring and anti-inflammatory properties. For instance, Bio Tissue Inc offers AmnioGraft to treat ocular surface indications like corneal ulcers, dry eye, chemical burns, etc. Besides, AM is highly preferred in developing regions since it is cheaper than allografts.
Competitive Analysis
For any company, acquisitions and agreements ensure expansion in business footings. Acquisitions, for instance, are quicker, cheaper, and less risky compared to other methods to extend volume sales. On the other hand, agreements are crucial to eliminating disagreements, confusion, or changes that may transpire during the course of the business period.
Notable acquisitions and agreements that support the market’s development:
In February 2021, Katena Products Inc, a leading provider of premium ophthalmic instruments and devices, announced the acquisition of ASICO LLC to expand the ophthalmic surgical product line and lead in the innovation of new products.
Integra LifeSciences Corporation, in January 2021, acquired ACell Inc and its proprietary MatriStem UMB to offer comprehensive wound management solutions.
Celularity Inc and Oncternal Therapeutics Inc entered into a research partnership in September 2021 to examine placental-derived cellular treatments.
Celularity also collaborated with Imugene Ltd in August 2021 to employ Imugene’s CD19 oncolytic virus technology and its CD19 CYCART-19 to remedy solid tumors.
In Conclusion,
The amniotic membrane market has shown rapid and promising results in healing damaged tissues. From chemical burns to ulcers to the cornea, amnions have emerged as suitable membranes in wound care management. This indicates that the use of AM in medicine and therapies is expanding in various branches of medicine.
Amniotic membrane is quite important for body to initiate healing. It is a combination of tissues and cells, which acts as a foundation for re-growth of soft tissues. Amniotic membrane has wide-scale utility in eye surgery that acts like a biological bandage.
Amniotic Membrane Market: Significance & Global Performance
Amniotic membrane or amnion, a thin membrane on the inner side of the fetal placenta and composed of the epithelium, has emerged as an ideal source for tissue transplantation. Moreover, amnion has an array of biological properties, making it attractive for use in various surgical procedures, including ocular surface reconstruction and tissue engineering.
The advancements in anatomy have triggered significant investments in research and development of amniotic membrane applications. While AM has shown beneficial results in burn injuries, the upsurge in R&D investments has increased its use in eye surgery, cell therapy, stem cell research, and more, boosting the amniotic membrane market growth prospects.
In fact, the identification of new stem cells has increased the membrane’s potential, making it ideal for developing regenerative medicines. For instance, Organogenesis Holdings Inc, a leading regenerative medicine company, gained approval from the US FDA for ReNu, a cryopreserved amniotic suspension allograft, to manage symptoms related to knee osteoarthritis.
Amniotic Membrane Market - Global & Regional Trends
As per estimates, the global amniotic membrane market will display revenue growth at a CAGR of 7.01% during the forecast period 2022-2028.
Considering the evolving healthcare sector, the amniotic membrane market is expected to witness tremendous growth in the Asia-Pacific nations. Estimates suggest that approximately half a billion people in the region will be 65 or older by 2025. This change in demographics, in addition to a shift in consumer expectations, will widen the market’s scope. In this regard, the growing demand for chronic care management will expand amnion application in ophthalmology, burn injuries, and cosmetic surgeries, among others.
Additionally, amniotic membrane transplantation has gained momentum in various conjunctival and corneal diseases, signaling opportunistic growth for players in the APAC region. Considering its growth in North America, amnions have proven advantageous in treating limbal stem cell deficiency, providing support and protection to transplanted limbal tissues and stem cells. Recently, in Canada, numerous techniques have been developed to dehydrate amnion while preserving the wound-healing properties to formulate a temperature-stable allograft.
Furthermore, the United Kingdom is the center of research and development of amniotic membrane applications in Europe. Several hospitals, such as NuVision, have gained expertise in providing AM treatments. Amniotic membrane treatments are gaining center stage across the nation, given the technological advancements. For instance, in November 2021, several ophthalmologists shared their innovations of AM application in treating ocular surface conditions through a webinar sponsored by NuVision Biotherapies Ltd.
Market by Application – Expert Outlook
Surgical Wounds: Human amniotic membrane has been used for treating acute and chronic wounds, decreasing infection and pain while accelerating the healing time. The surgical wound segment dominates the overall market and is expected to maintain its stronghold till 2028. Although a plethora of wound dressings are available, chronic wounds remain a major medical concern. As a result, chronic wounds awareness programs largely support amnion application. For instance, the Wound Healing and Hyperbaric Center at Carteret Health Care, a Healogic Network member, is engaged in raising awareness of chronic wounds, providing advanced therapies.
Ophthalmology: The rise in chronic and infectious diseases has resulted in a global rise in surgeries, boosting the market’s potential. Amniotic membrane is rapidly used in ophthalmic surgeries to initiate faster recovery and decrease inflammation. Amnion has become crucial in eye treatments, given its anti-scarring and anti-inflammatory properties. For instance, Bio Tissue Inc offers AmnioGraft to treat ocular surface indications like corneal ulcers, dry eye, chemical burns, etc. Besides, AM is highly preferred in developing regions since it is cheaper than allografts.
Competitive Analysis
For any company, acquisitions and agreements ensure expansion in business footings. Acquisitions, for instance, are quicker, cheaper, and less risky compared to other methods to extend volume sales. On the other hand, agreements are crucial to eliminating disagreements, confusion, or changes that may transpire during the course of the business period.
Notable acquisitions and agreements that support the market’s development:
In February 2021, Katena Products Inc, a leading provider of premium ophthalmic instruments and devices, announced the acquisition of ASICO LLC to expand the ophthalmic surgical product line and lead in the innovation of new products.
Integra LifeSciences Corporation, in January 2021, acquired ACell Inc and its proprietary MatriStem UMB to offer comprehensive wound management solutions.
Celularity Inc and Oncternal Therapeutics Inc entered into a research partnership in September 2021 to examine placental-derived cellular treatments.
Celularity also collaborated with Imugene Ltd in August 2021 to employ Imugene’s CD19 oncolytic virus technology and its CD19 CYCART-19 to remedy solid tumors.
In Conclusion,
The amniotic membrane market has shown rapid and promising results in healing damaged tissues. From chemical burns to ulcers to the cornea, amnions have emerged as suitable membranes in wound care management. This indicates that the use of AM in medicine and therapies is expanding in various branches of medicine.
AM Potential in Tissue Engineering to Drive Amniotic Membrane Market’s Growth
Triton Market Research presents the Global Amniotic Membrane Market report sectioned by End-users (Specialized Clinics, Hospitals, Ambulatory Surgical Wounds, Research Centers & Laboratories), Application (Ophthalmology, Surgical Wounds, Other Applications), Type (Lyophilization Amniotic Membrane, Cryopreserved Amniotic Membrane), and by Geography (Latin America, Asia-Pacific, Europe, North America, Middle East and Africa). The report also discusses the Market Summary, Industry Outlook, Impact of COVID-19, Key Insights, Porter’s Five Forces Analysis, Market Attractiveness Index, Vendor Scorecard, Key Market Strategies, Drivers, Challenges, Opportunities, Competitive Landscape, Research Methodology & Scope, Global Market Size, Forecasts & Analysis (2022-2028).
Based on Triton’s research report, the global amniotic membrane market is expected to grow at a CAGR of 7.01% during the forecast period 2022-2028.
Request Free Sample Report:
https://www.tritonmarketresearch.com/reports/amniotic-membrane-market#request-free-sample
The amniotic membrane refers to the innermost layer of the fetal placenta. It is used for various treatments, including ocular surface repair and tissue transplantation.
Amniotic membrane or amnion has shown potential to be used as a scaffold in numerous tissue engineering applications. In this regard, the genipin-crosslinked group (clAM) of human amniotic membranes has better biostability and biocompatibility. Therefore, the application of amnion in tissue engineering creates novel growth opportunities for the amniotic membrane market globally.
On the contrary, the use of an amniotic membrane is limited as its use in treating lung and other organ damages is still under research. Hence, the limited use of amnion restricts the amniotic membrane market’s global growth.
The Asia-Pacific region is anticipated to witness the fastest growth over the forecast period. The region’s robust growth is mainly owing to the growing applications of amnion across China, India, and South Korea. In China, the rising number of accidents and cosmetic surgery trends have increased the application of AM for various treatments. The demand for eye surgeries to prevent glasses is another reason supporting amniotic membrane use in eye treatments. Therefore, as stated above, all these factors drive the amniotic membrane market on a progressive path across the region.
The notable companies in the amniotic membrane market include Sky Biologics LLC, Human Regenerative Technologies, Labtician Ophthalmics Inc, Amino Technology LLC, Surgenix LLC, Organogenesis, MiMedx, Amniox Medical Inc, Celularity Inc, Integra Lifescience Corp, Bio Tissue Inc, Smith and Nephew Plc, Surgilogix LLC, and Katena Products Inc.
The market is heavily fragmented; however, it is expected to witness significant development over the forecast period. The barrier of entry is high as players require high capital investment in research, clinical trials, and more. Hence, the threat of new players is low. Further, since the market is emerging with no product differentiation, innovation and research are expected to drive the competition among existing players. This indicates the competition levels to be moderate over the forecast period.
Contact Us:
Phone: +44 7441 911839
Amniotic Membrane Market: Product and Application Outlook
Globally, burn cases, trauma wounds, and surgeries are on the rise. According to the Global Burden of Disease, almost 90 million burn cases were registered worldwide in 2017. The amniotic membrane’s anti-inflammatory and anti-scarring properties have been instrumental in reducing discomfort and inflammation, thereby contributing to its resurging use in multiple applications. Subsequently, the increased awareness regarding product innovations and benefits has significantly impacted AM’s expansion. As per Inkwood Research analysis, the global amniotic membrane market is projected to evolve at 7.03% of CAGR between 2022 and 2030.
Amniotic Membrane: Structure and Function
The amniotic membrane comprises several layers and can be divided into two different layers, the chorion and amnion, further separated by a jelly-like layer. It entails three material types, regenerative molecules, biologically active cells, and collagen and extracellular matrix. Collagen adds structural strength to the membrane, whereas extracellular matrix provides structure and has specialized proteins like laminins, fibronectin, proteoglycans, etc.
Further, biologically active cells comprise stem cells that revitalize new cellular materials within the membrane lining. Regenerative molecules are central to growth and healing, encompassing metalloproteinases, platelet-derived growth factors, and fibroblast growth factors.
Amniotic Membrane Market by Application
Amniotic membrane (AM) has varied applications in regenerative medicine. Over the years, its clinical applications have advanced from corneal and skin repair to solubilized powder injections, amniotic cytokine extract, and micronized dehydrated membrane to regenerate tendons, cartilage, and muscles. Also, AM is a source of several stem cells types and is a highly biocompatible natural scaffold. Thus, with the increasing number of reconstructive and cosmetic surgeries globally, the surgical wounds segment is expected to continue its revenue growth trend throughout the forecast period.
Some of the prominent and resurging AM applications are:
1. Ophthalmology
Ophthalmology is the fastest-growing segment in the amniotic membrane application market. It has become one of the key adjuvant treatments in ophthalmic surgery, with advancements in tissue engineering, ease of use, enhanced obtaining process, and tectonic properties. Additionally, tissue engineering has enabled its use in classic forms and drops.
2. Skin Graft
Amniotic membrane was first used as a skin substitute in 1910. As an alternative for the dressing of skin graft donor sites, it offers substantial benefits like decreased number of dressing changes and enhanced wound healing process.
Additionally, it has similar features as human skin since it originates from ectoderm. As per studies, it is further evaluated to prevent associated infections, traumas, and dehydration conventionally observed in disrupted skin wounds. Moreover, AM serves as a cost-efficient material for wound dressing.
3. Sports Medicine
AM has promising applications in sports medicine, since it is a source of highly organized collagen, matrix proteins, immunomodulators, anti-inflammatory and anti-fibrotic cytokines, and pluripotent cells. When applied as tissue engineering scaffolds, such aspects enhance tissue organization in treating and healing arthritic joints.
Also, around 14 companies offer commercial AM products despite sports medicine leaning towards animal and in vitro studies. Studies state that such products’ formulation changes their mechanical and biological properties, and an in-depth understanding of differences will enable the use of AM-derived products in sports medicine research.
Product Innovations: Amniotic Membrane Market Trend 2022
The development of various preservation methods has helped overcome AM’s limitations like high disease transmission risk and limited shelf life. Alongside, commercially available amniotic products implement dehydration preservation methods or cryopreservation methods to sustain the regenerative properties of amniotic membranes.
Moreover, there are over 80 commercial placenta membrane products available in the market. Some prominent firms operating in the market include Katena Products Inc, Bio-Tissue Inc, MIMEDX, Amino Technology LLC, etc.
The two leading AM products are cryopreserved AM and dehydrated AM, with the former harboring the largest revenue share in the product segment.
Dehydrated Amniotic Membranes
These are traditionally used in surgeries associated with ocular surface reconstruction. They are obtained from the human placenta surface after a healthy birth, wherein the donor tissue is evaluated for communicable diseases. However, matching donors is not a requisite since donor tissue is absorbed through the healing process.
In addition, dehydration enables AM tissue storage in a shelf-stable state and its active biological components preservation, required for medical uses. Dehydrated AM is used for several applications, the most common being treating neurotrophic corneal ulcer, a non-healing ocular surface defect. Besides, it can be employed to minimize scar tissue during ocular surface healing.
Cryopreserved Amniotic Membranes
These retain the specific biologic matrix that facilitates AM’s regenerative healing and anti-inflammatory properties, leading to fewer clinic visits and long-term relief. This is because cryopreserved amniotic membranes last longer on the eye. Also, these are FDA-approved for their anti-scarring and anti-angiogenesis properties. Moreover, cryopreserved AMs are advantageous compared to other therapies in terms of corneal defects.
The Progress Here on:
Amniotic membrane has had clinical applications for 100 years. Despite a slow start in clinical use, it has made inroads into several fields of medicine and surgery in the last 50 years. Besides, its beneficial properties and growing availability due to innovative storage methods offer lucrative growth opportunities for the global amniotic membrane market.